These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11122072)

  • 21. The Depo-Provera public hearing.
    Dening FC
    Midwives Chron; 1983 Jul; 96(1146):246. PubMed ID: 6225940
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug regulation in the United States and the United Kingdom: the Depo-Provera story.
    Richard BW; Lasagna L
    Ann Intern Med; 1987 Jun; 106(6):886-91. PubMed ID: 2953290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.
    Nooh AM; Abdeldayem HM; Girbash EF; Arafa EM; Atwa K; Abdel-Raouf SM
    Reprod Sci; 2016 Apr; 23(4):448-54. PubMed ID: 26718306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Counseling teens and young women on Depo-Provera.
    Tonelli M; Nicoletti A
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):297-8. PubMed ID: 16171737
    [No Abstract]   [Full Text] [Related]  

  • 25. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate.
    Hapgood JP
    Endocrinology; 2013 Mar; 154(3):985-8. PubMed ID: 23429710
    [No Abstract]   [Full Text] [Related]  

  • 27. Depo-Provera: an injectable contraceptive.
    Earl DT; David DJ
    Am Fam Physician; 1994 Mar; 49(4):891-4, 897-8. PubMed ID: 8116522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medroxyprogesterone (Depo Provera) and breast cancer.
    McCowan L
    N Z Med J; 1990 May; 103(889):225-6. PubMed ID: 2140436
    [No Abstract]   [Full Text] [Related]  

  • 29. Critical Review: Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism.
    Hickey M; Marino JL; Tachedjian G
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):1-7. PubMed ID: 26761267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State also pays for Depo-Provera.
    Hanson MS
    Minn Med; 1991 Jun; 74(6):7-8. PubMed ID: 1830920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depo-provera. A lesson in communication.
    Dennerstein G
    Aust Fam Physician; 1988 Mar; 17(3):176-8. PubMed ID: 2965569
    [No Abstract]   [Full Text] [Related]  

  • 32. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
    Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
    Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depo-Provera: new concerns--same issues?
    Robinson K
    AWHONN Lifelines; 2005; 9(3):214-7. PubMed ID: 16114743
    [No Abstract]   [Full Text] [Related]  

  • 34. Injectable contraception.
    Haider S; Darney PD
    Clin Obstet Gynecol; 2007 Dec; 50(4):898-906. PubMed ID: 17982332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depo-Provera--missing the point?
    Fennessy S
    Aust Fam Physician; 1988 Oct; 17(10):839-40. PubMed ID: 2977094
    [No Abstract]   [Full Text] [Related]  

  • 36. Depo Provera and breast cancer.
    McCowan L; Farquhar C; Roke C; Liddell H; Roberts H; Thakurdas N; Wilson J; Say PJ; McClure F
    N Z Med J; 1991 Jan; 104(904):16-7. PubMed ID: 1826144
    [No Abstract]   [Full Text] [Related]  

  • 37. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
    J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The case for depo provera.
    Cooling H; Christopher E
    Health Visit; 1989 Oct; 62(10):320. PubMed ID: 2530193
    [No Abstract]   [Full Text] [Related]  

  • 39. Anaphylaxis from medroxyprogesterone acetate.
    Selo-Ojeme DO; Tillisi A; Welch CC
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1045-6. PubMed ID: 15121602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of Depo-Provera in East London.
    Savage W
    Fertil Contracept; 1978 Jul; 2(3):41-7. PubMed ID: 12260723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.